ADC Archives - Page 3 of 6 - Onco'Zine

Home Tags ADC

Doctor discussing treatment options with a patient.

FDA Approves Novel Treatments for Metastatic Urothelial Cancer – But More...

Andrea Maddox-Smith - December 20, 2019

Seattle Genetics. Exhibition booth during the 2019 annual meeting of the American Society of Medical Oncology (ASCO). In the back of the booth the enfortumab vedotin presentation.

FDA Approves New Drug for Advanced Bladder Cancer

Peter Hofland, Ph.D - December 19, 2019

Enfortumab Vedotin + Pembrolizumab to be Evaluated in Metastatic Bladder Cancer

Peter Hofland, Ph.D - December 3, 2019

Zymeworks Awarded Best ADC Platform Technology at Annual Event

Peter Hofland, Ph.D - October 11, 2019

General images of ESMO 2019 Congress being held in Barcelona, Spain, September 27 - October 1, 2019. Courtesy European Society for Medical Oncology (ESMO). Used with Permission.

ESMO 2019: FORWARD I Study Evaluating Mirvetuximab Soravtansine Did Not Meet...

Peter Hofland, Ph.D - September 29, 2019

General images of ESMO 2019 Congress being held in Barcelona, Spain, September 27 - October 1, 2019. Courtesy European Society for Medical Oncology (ESMO). Used with Permission.

ESMO 2019: Enfortumab Vedotin + Pembrolizumab Shows High ORR in Bladder...

Peter Hofland, Ph.D - September 28, 2019

The ceramic dragon fountain in the Parc Guell designed by Antoni Gaudi, Barcelona, Spain.

ESMO 2019: Seattle Genetics to Present Latest Study Data – Becomes...

Peter Hofland, Ph.D - September 17, 2019

Seattle Genetics. Exhibition booth during the 2019 annual meeting of the American Society of Medical Oncology (ASCO). In the back of the booth the enfortumab vedotin presentation.

Biologics License Application and Priority Review for Enfortumab Vedotin in Urothelial...

Peter Hofland, Ph.D - September 16, 2019

Investigational ADC is Well Tolerated with Partial Dose-dependent Response in NSCLC

Peter Hofland, Ph.D - September 11, 2019

Featured Image: Daiichi Sankyo Booth at the annual meeting of the American Association for Cancer Research (AACR) 2018 Courtesy: © 2017 – 2018. Sunvalley Communication, LLC / Evan Wendt. Used with permission.

WCLC 2019: Daiichi Sankyo to Present Results from First-in-class HER3...

Peter Hofland, Ph.D - August 27, 2019

1 234...6 Page 3 of 6

LATEST NEWS

Pfizer Agrees to Acquire Seagen for US $ 43 Billion

Editorial Team - March 13, 2023

Byondis Plans First-in-human Dose Escalation/Expansion Study With the SIRPα-directed BYON4228

Danielle Garcia - February 27, 2023

FDA Priority Review of NDA for Nirogacestat for the Treatment of Rare Desmoid Tumors

Editorial Team - February 27, 2023

Finding a Cure for Nonalcoholic Fatty Liver Disease

Editorial Team - February 23, 2023

Why Do Politicians Weaponize Medicare? Because It Works!

Julie Rovner - February 21, 2023

Press Releases | Cancer

Deep Bio’s Novel Study Results Reaffirm Its Global Presence March 14, 2023
USCAP 2023 is Deep Bio’s sixth consecutive year of presenting research abstracts(PRWeb March 14, 2023)Read the full story at https://www.prweb.com/releases/2023/03/prweb19209392.htm
Study Adds Support for Cxbladder Monitor Use in Cancer Surveillance March 14, 2023
Cancer diagnostics company Pacific Edge (NZX, ASX: PEB) welcomes the release of new research supporting the clinical utility of the company’s genomic biomarker test Cxbladder Monitor in the...(PRWeb March 14, 2023)Read the full story at https://www.prweb.com/releases/2023/3/prweb19220555.htm
RSNA: Huge Study Finds Tomosynthesis Better at Breast Cancer Detection March 14, 2023
In a study of over a million women, digital breast tomosynthesis (DBT) showed improved breast cancer screening outcomes over screening with standard digital mammography alone. The results of the study...(PRWeb March 14, 2023)Read the full story at https://www.prweb.com/releases/rsna_huge_study_finds_tomosynthesis_better_at_breast_cancer_detection/prweb19221463.htm